Active Cells, Biochemistry & Physiology Genetics & Molecular Biology

Discovery and Characterisation of Undefined Ubiquitin and Ubiquitin-like E3 Ligases

In plain English

AI plain-English summary

Cells tag unwanted proteins with a small molecular marker called ubiquitin to mark them for destruction, but the enzymes that attach these tags are still being discovered. This matters because ubiquitin and its relatives, ubiquitin-like proteins (Ubls), control nearly every process inside a cell—from how it divides to how it fights viruses. When these tagging systems go wrong, they contribute to cancer and other diseases. The E3 ligase enzymes that select which proteins get tagged are prime targets for new drugs, yet many E3s remain unknown, and there is no reliable way to measure their activity inside living cells. The researcher plans to find new E3 ligases, map their atomic structures, and develop chemical probes to track how they work. A key goal is to create a general, quantitative method to measure E3 activity in cells—a tool that currently does not exist. If successful, this would accelerate the development of next-generation medicines that can switch specific E3s on or off, potentially leading to more precise treatments for cancer and viral infections. This is fundamental science: the immediate payoff is a deeper understanding of cellular control systems, but past work on ubiquitin has already led to drugs for multiple myeloma, so the practical potential is real.

View original technical description
Modification of substrates with the small protein ubiquitin (Ub) regulates virtually all aspects of the cell. Additionally, modification with ubiquitin- like proteins (Ubls) has been implicated with important processes such innate antiviral immunity and cancer progression. E3 ligase enzymes (E3s) select specific substrates for modification and have great therapeutic importance. We have shown that novel E3s with unique mechanisms and unanticipated substrate biology remain to be discovered. Furthermore, to decipher the cellular functions of the growing complement of E3s in health and disease, a general and quantitative approach for measuring cellular E3 activity is urgently needed. In aim 1 of this proposal I will discover novel ubiquitin E3 machineries and establish their cellular functions. In Aim 2, newly discovered E3s will be carefully selected for structural characterisation and their catalytic mechanisms will be delineated at an atomic level. In Aim 3 I will develop chemical biological probes for Ubls allowing me to discover their missing E3s and gain insights into their cellular roles. In Aim 4 I will develop urgently needed global and quantitative technology that will not only expedite the study of E3s, but also accelerate the development of next generation medicines that modulate their activity.

View the original record at the funder ↗

Researchers

Satpal Virdee (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Activity-based Proteomics of E3 Ligases
Unlocking the therapeutic potential of E3 ubiquitin ligases through structure-function studies and Cryo-EM
Assessing the physiological relevance and molecular mechanisms of non-canonical ubiquitylation
Selective inhibitors of E3 ubiquitin ligases to treat neurodegenerative diseases
Molecular mechanisms of the ubiquitin system

Original classification

Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.